Literature DB >> 16682795

The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study.

Corina Pennanen1, Cristina Testa, Marina Boccardi, Mikko P Laakso, Merja Hallikainen, Eeva-Liisa Helkala, Tuomo Hänninen, Miia Kivipelto, Mervi Könönen, Aulikki Nissinen, Susanna Tervo, Matti Vanhanen, Ritva Vanninen, Giovani B Frisoni, Hilkka Soininen.   

Abstract

We investigated the effect of apolipoprotein E (ApoE) on the whole brain in 51 individuals with mild cognitive impairment using voxel-based morphometry. Between cases heterozygous for the ApoE epsilon4 (n = 15) and those who were ApoE epsilon4 noncarriers (n = 28), only the right parahippocampal gyrus, with the entorhinal cortex included, reached the level of statistical significance. In cases homozygous for the epsilon4 allele (n = 8) versus noncarriers, the greatest atrophy was located in the right amygdala followed by the right parahippocampal gyrus, the left amygdala and the left medial dorsal thalamic nucleus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682795     DOI: 10.1159/000093263

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  3 in total

Review 1.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

2.  APOE*E4 Is Associated with Gray Matter Loss in the Posterior Cingulate Cortex in Healthy Elderly Controls Subsequently Developing Subtle Cognitive Decline.

Authors:  S Haller; M-L Montandon; C Rodriguez; M Ackermann; F R Herrmann; P Giannakopoulos
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

3.  Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.

Authors:  M Pievani; P E Rasser; S Galluzzi; L Benussi; R Ghidoni; F Sabattoli; M Bonetti; G Binetti; P M Thompson; G B Frisoni
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.